Results 14,441-14,460 of 21,489 for speaker:Alan Kelly

Public Accounts Committee: Special Report No. 94 of the Comptroller and Auditor General: National Asset Management Agency Sale of Project Eagle (Resumed) (16 Nov 2016)

Alan Kelly: Would Mr. McGuinness officially answer my question: does he believe that the First Minister at the time misled him?

Public Accounts Committee: Special Report No. 94 of the Comptroller and Auditor General: National Asset Management Agency Sale of Project Eagle (Resumed) (16 Nov 2016)

Alan Kelly: "Yes" or "no".

Public Accounts Committee: Special Report No. 94 of the Comptroller and Auditor General: National Asset Management Agency Sale of Project Eagle (Resumed) (16 Nov 2016)

Alan Kelly: It is a simple question. It is a "yes" or "no" answer.

Public Accounts Committee: Special Report No. 94 of the Comptroller and Auditor General: National Asset Management Agency Sale of Project Eagle (Resumed) (16 Nov 2016)

Alan Kelly: I am not looking for a headline.

Public Accounts Committee: Special Report No. 94 of the Comptroller and Auditor General: National Asset Management Agency Sale of Project Eagle (Resumed) (16 Nov 2016)

Alan Kelly: He either misled Mr. McGuinness or he did not.

Public Accounts Committee: Special Report No. 94 of the Comptroller and Auditor General: National Asset Management Agency Sale of Project Eagle (Resumed) (16 Nov 2016)

Alan Kelly: I do not. I am only asking a question.

Select Committee on the Future of Healthcare: Health Service Reform: Hospital Groups (16 Nov 2016)

Alan Kelly: The witnesses are very welcome. The Chairman is cracking the whip so I will just fire out the questions because we are under time constraints. Do the witnesses believe the group structures within the HSE are working? Could they be improved? Obviously, they are not perfect and if they can be improved, how can that be done? How big an issue is the fact that they do not align with the...

Select Committee on the Future of Healthcare: Health Service Reform: Hospital Groups (16 Nov 2016)

Alan Kelly: I think this is a critical point for our committee because what Ms Cowan outlined works. To have somebody come into this committee and say that, effectively, the priority for her group is take funding and put it into the community is something we all agree with.

Select Committee on the Future of Healthcare: Health Service Reform: Hospital Groups (16 Nov 2016)

Alan Kelly: I know. What interests me is whether the other witnesses agree with that 100%. Would they prefer to see a model-----

Select Committee on the Future of Healthcare: Health Service Reform: Hospital Groups (16 Nov 2016)

Alan Kelly: A pot of money has to be found somewhere, even with the Supplementary Estimate, if targets are not met.

Select Committee on the Future of Healthcare: Health Service Reform: Hospital Groups (16 Nov 2016)

Alan Kelly: Exactly. We are finding out here that there has been no impact on patients, so nothing has been cut. Given the fact that the hospital groups have to meet these targets, it would be interesting if the committee could obtain a breakdown over the year of the income derived from private patients. From anecdotal evidence, I am concerned that there is a spike in private income coming towards the...

Select Committee on the Future of Healthcare: Health Service Reform: Hospital Groups (16 Nov 2016)

Alan Kelly: How can the staff at a level 3 hospital not be as good at those at a level 4 facility?

Select Committee on the Future of Healthcare: Health Service Reform: Hospital Groups (16 Nov 2016)

Alan Kelly: It is in the legislation.

Select Committee on the Future of Healthcare: Health Service Reform: Hospital Groups (16 Nov 2016)

Alan Kelly: Ms Cowan wanted to reply.

Written Answers — Department of Health: Legislative Measures (16 Nov 2016)

Alan Kelly: 176. To ask the Minister for Health further to his attendance at the Oireachtas health committee on 28 September 2016, the number of meetings and level of consultation he or any of his officials have had with a person (details supplied) in respect of the Health (Pricing and Supply of Medical Goods) (Amendment) Bill 2016; and if he will make a statement on the matter. [35284/16]

Written Answers — Department of Health: Legislative Measures (16 Nov 2016)

Alan Kelly: 177. To ask the Minister for Health further to his attendance at the Oireachtas health committee on 28 September 2016, if he or any of his officials have any meetings planned with a person (details supplied) to discuss or consult on the Health (Pricing and Supply of Medical Goods) (Amendment) Bill 2016; and if he will make a statement on the matter. [35285/16]

Written Answers — Department of Health: Medicinal Products Prices (16 Nov 2016)

Alan Kelly: 178. To ask the Minister for Health if a rebate scheme formed part of the previous medicine pricing agreement, agreed between his Department and the Irish Pharmaceutical Healthcare Association, which applied up to November 2015; if so, the way in which this rebate scheme was applied and operated; the total revenues which were generated by these rebates over the lifetime of the agreement; the...

Written Answers — Department of Health: Medicinal Products Prices (16 Nov 2016)

Alan Kelly: 179. To ask the Minister for Health the way in which the rebate scheme which forms part of the current medicine pricing agreement, agreed between his Department and the Irish Pharmaceutical Healthcare Association, will apply and be operated; the total revenues which his Department anticipates will be generated by these rebates over the lifetime of the agreement; the amounts expected to be...

Written Answers — Department of Health: Medicinal Products Prices (16 Nov 2016)

Alan Kelly: 180. To ask the Minister for Health the way in which the HSE charges and calculates rebates for biosimilar drugs that are approved and for sale in the market; and if he will make a statement on the matter. [35288/16]

Companies (Accounting) Bill 2016 - Second Stage: Second Stage (Resumed) (15 Nov 2016)

Alan Kelly: Sorry, I cannot keep up with the junior ministerial positions.